248 related articles for article (PubMed ID: 9013904)
1. Prosthetic above-knee femoropopliteal bypass grafting: results of a multicenter randomized prospective trial. Above-Knee Femoropopliteal Study Group.
Abbott WM; Green RM; Matsumoto T; Wheeler JR; Miller N; Veith FJ; Suggs WD; Hollier L; Money S; Garrett HE
J Vasc Surg; 1997 Jan; 25(1):19-28. PubMed ID: 9013904
[TBL] [Abstract][Full Text] [Related]
2. A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.
Rychlik IJ; Davey P; Murphy J; O'Donnell ME
J Vasc Surg; 2014 Aug; 60(2):506-15. PubMed ID: 24973288
[TBL] [Abstract][Full Text] [Related]
3. Graft type for femoro-popliteal bypass surgery.
Ambler GK; Twine CP
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD001487. PubMed ID: 29429146
[TBL] [Abstract][Full Text] [Related]
4. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Pearl G; Theune B; Black S
J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
[TBL] [Abstract][Full Text] [Related]
5. A contemporary meta-analysis of Dacron versus polytetrafluoroethylene grafts for femoropopliteal bypass grafting.
Takagi H; Goto SN; Matsui M; Manabe H; Umemoto T
J Vasc Surg; 2010 Jul; 52(1):232-6. PubMed ID: 20471778
[TBL] [Abstract][Full Text] [Related]
6. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Hohman S; Pearl G; Theune B
J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
[TBL] [Abstract][Full Text] [Related]
7. Heparin-bonded expanded polytetrafluoroethylene femoropopliteal bypass grafts outperform expanded polytetrafluoroethylene grafts without heparin in a long-term comparison.
Samson RH; Morales R; Showalter DP; Lepore MR; Nair DG
J Vasc Surg; 2016 Sep; 64(3):638-47. PubMed ID: 27139782
[TBL] [Abstract][Full Text] [Related]
8. [Factors determining late patency of aortobifemoral bypass graft].
Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
[TBL] [Abstract][Full Text] [Related]
9. A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study.
Johnson WC; Lee KK
J Vasc Surg; 2000 Aug; 32(2):268-77. PubMed ID: 10917986
[TBL] [Abstract][Full Text] [Related]
10. Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: five-year results of a prospective randomized multicenter clinical trial.
Devine C; McCollum C;
J Vasc Surg; 2004 Nov; 40(5):924-31. PubMed ID: 15557906
[TBL] [Abstract][Full Text] [Related]
11. Fluoropolymer coated Dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: a multicentre trial.
Robinson BI; Fletcher JP;
ANZ J Surg; 2003 Mar; 73(3):95-9. PubMed ID: 12608965
[TBL] [Abstract][Full Text] [Related]
12. Outcome of the FUSION vascular graft for above-knee femoropopliteal bypass.
Assadian A; Eckstein HH;
J Vasc Surg; 2015 Mar; 61(3):713-9.e1. PubMed ID: 25498193
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass.
Lumsden AB; Morrissey NJ;
J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929
[TBL] [Abstract][Full Text] [Related]
14. Dacron vs. polytetrafluoroethylene grafts for femoropopliteal bypass: a prospective randomised multicentre trial.
Post S; Kraus T; Müller-Reinartz U; Weiss C; Kortmann H; Quentmeier A; Winkler M; Husfeldt KJ; Allenberg JR
Eur J Vasc Endovasc Surg; 2001 Sep; 22(3):226-31. PubMed ID: 11506515
[TBL] [Abstract][Full Text] [Related]
15. The performance of femoropopliteal bypasses using polytetrafluoroethylene above the knee versus autogenous vein below the knee.
Woratyla SP; Darling RC; Chang BB; Paty PS; Kreienberg PB; Leather RP; Shah DM
Am J Surg; 1997 Aug; 174(2):169-72. PubMed ID: 9293837
[TBL] [Abstract][Full Text] [Related]
16. Graft type for femoro-popliteal bypass surgery.
Mamode N; Scott RN
Cochrane Database Syst Rev; 2000; (2):CD001487. PubMed ID: 10796649
[TBL] [Abstract][Full Text] [Related]
17. [Dacron and polytetrafluoroethylene aorto-bifemoral grafts].
Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanović PL; Velimirović LB; Marković DM; Pejkić SL; Pavlović G
Srp Arh Celok Lek; 1997; 125(3-4):75-83. PubMed ID: 9221522
[TBL] [Abstract][Full Text] [Related]
18. Dacron or ePTFE for femoro-popliteal above-knee bypass grafting: short- and long-term results of a multicentre randomised trial.
van Det RJ; Vriens BH; van der Palen J; Geelkerken RH
Eur J Vasc Endovasc Surg; 2009 Apr; 37(4):457-63. PubMed ID: 19231253
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomized multicentre comparison of expanded polytetrafluoroethylene and gelatin-sealed knitted Dacron grafts for femoropopliteal bypass.
Robinson BI; Fletcher JP; Tomlinson P; Allen RD; Hazelton SJ; Richardson AJ; Stuchbery K
Cardiovasc Surg; 1999 Mar; 7(2):214-8. PubMed ID: 10353674
[TBL] [Abstract][Full Text] [Related]
20. Is the preferential use of polytetrafluoroethylene grafts for femoropopliteal bypass justified?
Quiñones-Baldrich WJ; Busuttil RW; Baker JD; Vescera CL; Ahn SS; Machleder HI; Moore WS
J Vasc Surg; 1988 Sep; 8(3):219-28. PubMed ID: 3418827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
